AGIO
Price
$32.38
Change
+$0.56 (+1.76%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.85B
26 days until earnings call
RAPT
Price
$1.20
Change
+$0.01 (+0.84%)
Updated
Jan 17 closing price
Capitalization
41.95M
47 days until earnings call
Ad is loading...

AGIO vs RAPT

Header iconAGIO vs RAPT Comparison
Open Charts AGIO vs RAPTBanner chart's image
Agios Pharmaceuticals
Price$32.38
Change+$0.56 (+1.76%)
Volume$31.19K
Capitalization1.85B
RAPT Therapeutics
Price$1.20
Change+$0.01 (+0.84%)
Volume$885.45K
Capitalization41.95M
AGIO vs RAPT Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. RAPT commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and RAPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (AGIO: $32.42 vs. RAPT: $1.20)
Brand notoriety: AGIO and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 85% vs. RAPT: 20%
Market capitalization -- AGIO: $1.85B vs. RAPT: $41.95M
AGIO [@Biotechnology] is valued at $1.85B. RAPT’s [@Biotechnology] market capitalization is $41.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 3 bearish.
  • RAPT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than RAPT.

Price Growth

AGIO (@Biotechnology) experienced а -5.81% price change this week, while RAPT (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

AGIO is expected to report earnings on May 01, 2025.

RAPT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($1.85B) has a higher market cap than RAPT($41.9M). AGIO YTD gains are higher at: -1.339 vs. RAPT (-24.051). RAPT has higher annual earnings (EBITDA): -113.61M vs. AGIO (-401.29M). AGIO has more cash in the bank: 1.01B vs. RAPT (97.9M). RAPT has less debt than AGIO: RAPT (5.12M) vs AGIO (60.8M). AGIO has higher revenues than RAPT: AGIO (32.9M) vs RAPT (0).
AGIORAPTAGIO / RAPT
Capitalization1.85B41.9M4,413%
EBITDA-401.29M-113.61M353%
Gain YTD-1.339-24.0516%
P/E Ratio2.78N/A-
Revenue32.9M0-
Total Cash1.01B97.9M1,027%
Total Debt60.8M5.12M1,188%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIORAPT
RSI
ODDS (%)
Bullish Trend 11 days ago
59%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
80%
Bullish Trend 11 days ago
86%
Momentum
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
77%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
74%
Bullish Trend 11 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
76%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
Aroon
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNS0.680.08
+13.07%
Genius Group Limited
SA11.890.12
+1.02%
Seabridge Gold
IESC256.691.27
+0.50%
IES Holdings
WMB59.14-0.04
-0.07%
Williams Companies
MTLS7.60-0.26
-3.31%
Materialise NV

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with AXON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+1.89%
AXON - AGIO
45%
Loosely correlated
+1.37%
CORT - AGIO
44%
Loosely correlated
+1.60%
OLMA - AGIO
42%
Loosely correlated
+7.20%
INSM - AGIO
41%
Loosely correlated
-0.33%
RAPT - AGIO
41%
Loosely correlated
+0.84%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
+0.84%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
+1.37%
SNDX - RAPT
45%
Loosely correlated
+0.62%
OCUL - RAPT
42%
Loosely correlated
-0.50%
AGIO - RAPT
41%
Loosely correlated
+1.89%
More